Breast Cancer Research

official impact factor 5.79

Open Access Highly Access

Comparison of molecular phenotypes of ductal carcinoma in situ and invasive breast cancer

Rulla M Tamimi*, Heather J Baer, Jonathan Marotti, Mark Galan, Laurie Galaburda, Yineng Fu, Anne C Deitz, James L Connolly, Stuart J Schnitt, Graham A Colditz and Laura C Collins

Breast Cancer Research 2008, 10:R67 doi:10.1186/bcr2128

Accesses  

  • Last 30 days: 77 accesses
  • Last year: 1030 accesses
  • All time: 6186 accesses

Cited by

BioMed Central: 5 citations

Research   Open Access

Epidermal growth factor receptor in breast carcinoma: association between gene copy number and mutations

Ning Lv, Xiaoming Xie, Qidong Ge, Suxia Lin, Xi Wang, Yanan Kong, Hongliu Shi, Xinhua Xie, Weidong Wei Diagnostic Pathology 2011, 6:118 (2 December 2011)

Short report   Open Access

Very low prevalence of epidermal growth factor receptor (EGFR) protein expression and gene amplification in Saudi breast cancer patients

Mohamed A Shawarby, Dalal M Al-Tamimi, Ayesha Ahmed Diagnostic Pathology 2011, 6:57 (24 June 2011)

Research article   Open Access Highly Accessed

Epidemiology of breast cancer subtypes in two prospective cohort studies of breast cancer survivors

Marilyn L Kwan, Lawrence H Kushi, Erin Weltzien, Benjamin Maring, Susan E Kutner, Regan S Fulton, Marion M Lee, Christine B Ambrosone, Bette J Caan Breast Cancer Research 2009, 11:R31 (22 May 2009)

Letter   Free Highly Accessed

Luminal B breast tumors are not HER2 positive – authors' response

Rulla M Tamimi, Stuart J Schnitt, Graham A Colditz, Laura C Collins Breast Cancer Research 2008, 10:405 (26 September 2008)

Letter   Free

Luminal B breast tumors are not HER2 positive

Rohit Bhargava, David J Dabbs Breast Cancer Research 2008, 10:404 (26 September 2008)